Image
|
Figure Caption
Fig. 2 Removal of dystroglycan protein leads to abnormal development. Embryos injected with control MO at 24 hpf (A) and 48 hpf (E) and with a dystroglycan MO at 24 hpf (B) and 48 hpf (F). (C,D,G,H) Staining for dystroglycan in control (C,G) and dystroglycan morphant (D,H) embryos at 24 hpf (C,D) and 48 hpf (G,H).
Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Development